301211 亨迪药业
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额18,87096,073137,063250,795123,984
投资活动产生之现金流量净额46,748(1,109,462)(207,469)(179,865)229,647
筹资活动产生之现金流量净额(72,816)(139,871)(97,168)(77,390)1,405,139
汇率变动对现金及现金等价物的影响(121)2,0733,8104,935(4,421)
现金及现金等价物净增加/(减少)(7,318)(1,151,187)(163,762)(1,526)1,754,349
期初现金及现金等价物余额543,1401,694,2271,857,9891,859,515105,165
期末现金及现金等价物余额535,821543,0401,694,2271,857,9891,859,515